Abrdn PLC Astrazeneca PLC Transaction History

Abrdn PLC

$51.7 Billion
Q4 2024

A detailed history of Abrdn PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Abrdn PLC holds 1,401,489 shares of AZN stock, worth $105 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

1,401,489

Previous 1,362,316 2.88%

Holding current value

$105 Million

Previous $106 Million 13.5%

% of portfolio

0.18%

Previous 0.2%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	BUY	$63.2 - $79.58 $2.48 Million - $3.12 Million	39,173 Added 2.88%	1,401,489 $91.8 Million
Q3 2024 Oct 24, 2024	SELL	$76.67 - $87.62 $11.1 Million - $12.6 Million	-144,207 Reduced 9.57%	1,362,316 $106 Million
Q2 2024 Aug 09, 2024	BUY	$66.81 - $80.83 $697,964 - $844,431	10,447 Added 0.7%	1,506,523 $117 Million
Q1 2024 May 08, 2024	BUY	$61.03 - $69.57 $4.59 Million - $5.23 Million	75,200 Added 5.29%	1,496,076 $101 Million
Q4 2023 Jan 31, 2024	BUY	$61.89 - $69.28 $68.2 Million - $76.4 Million	1,102,490 Added 346.27%	1,420,876 $95.7 Million
Q3 2023 Nov 06, 2023	BUY	$64.85 - $71.7 $103,759 - $114,720	1,600 Added 0.51%	318,386 $21.6 Million
Q2 2023 Jun 20, 2024	SELL	$69.91 - $75.81 $69,910 - $75,810	-1,000 Reduced 0.31%	316,786 $22.7 Million
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $69,910 - $75,810	-1,000 Reduced 0.31%	316,786 $22.7 Million
Q1 2023 Jun 20, 2024	BUY	$63.15 - $71.6 $1.32 Million - $1.5 Million	20,900 Added 7.04%	317,786 $22.1 Million
Q1 2023 Apr 28, 2023	BUY	$63.15 - $71.6 $1.32 Million - $1.5 Million	20,900 Added 7.04%	317,786 $22.1 Million
Q4 2022 Jun 20, 2024	SELL	$54.21 - $70.44 $65 Million - $84.5 Million	-1,199,190 Reduced 80.16%	296,886 $20.1 Million
Q2 2022 Aug 05, 2022	SELL	$59.26 - $71.14 $1.76 Million - $2.11 Million	-29,709 Reduced 9.1%	296,886 $19.6 Million
Q1 2022 May 04, 2022	SELL	$55.72 - $67.12 $2.16 Million - $2.6 Million	-38,800 Reduced 10.62%	326,595 $21.7 Million
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $1.65 Million - $1.95 Million	-30,500 Reduced 7.7%	365,395 $21.3 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $1.37 Million - $1.5 Million	24,640 Added 6.64%	395,895 $23.8 Million
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $547,146 - $680,034	11,300 Added 3.14%	371,255 $22.2 Million
Q1 2021 May 06, 2021	BUY	$47.16 - $54.44 $56,591 - $65,328	1,200 Added 0.33%	359,955 $17.9 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $4.32 Million - $5.17 Million	89,055 Added 33.02%	358,755 $17.9 Million
Q3 2020 Oct 21, 2020	SELL	$53.07 - $61.1 $95,526 - $109,980	-1,800 Reduced 0.66%	269,700 $14.8 Million
Q1 2020 May 13, 2020	BUY	$37.79 - $51.33 $10.3 Million - $13.9 Million	271,500 New	271,500 $12.1 Million

Others Institutions Holding AZN

# of Institutions

1,368

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $232B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account